![]() |
市場調查報告書
商品編碼
2026894
遠距藥事照護市場預測至2034年:按服務、交付方式、設備、最終用戶和地區分類的全球分析Telepharmacy Market Forecasts to 2034 - Global Analysis By Service (Drug Therapy Monitoring, Patient Counselling and Other Services), By Delivery Mode (On-premises, Cloud-based and Web-based), Device, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球遠距藥事照護市場規模將達到 153 億美元,並在預測期內以 18.4% 的複合年成長率成長,到 2034 年將達到 590 億美元。
遠距藥事照護是指透過通訊和數位平台提供的遠端用藥服務。這使得藥劑師能夠遠端提供用藥諮詢、治療管理和配藥服務。遠距藥事照護改善了人們獲得藥學服務的途徑,尤其是在服務不足的地區,提高了患者的用藥依從性,並透過遠端對話和技術解決方案提供虛擬諮詢,從而支持患者照護和用藥。
根據美國國立衛生研究院 (NIH) 在 COVID-19 大流行期間對患者採用遠距藥事照護和親自到藥局就診的觀點和偏好進行的一項調查,約 77% 的受訪者更喜歡透過遠距藥事照護預約。
對遠端醫療解決方案的需求日益成長
遠端醫療解決方案需求的不斷成長正在推動遠距藥事照護市場的發展。這種需求主要源自於地理限制、藥局資源匱乏以及農村和醫療服務不足地區對便利醫療保健的需求。遠距藥事照護透過提供遠距用藥服務(例如藥物諮詢、治療管理和處方箋更新)來應對這些挑戰。人們對虛擬互動方式的日益偏好,以及對便利及時醫療保健的需求,使得遠距藥事照護成為至關重要的解決方案,推動了其普及和市場成長。
不同司法管轄區的許可挑戰
地區和州的具體法規及許可要求導致合規程序複雜。跨多個司法管轄區運作的遠距藥事照護服務必須應對不同的法律體制,這通常涉及嚴格且耗時的許可流程。遵守不同的法規會使營運複雜化,增加行政負擔,並阻礙市場快速擴張。滿足不同司法管轄區的各種許可要求這項挑戰阻礙了遠距藥事照護服務的順利開展,並限制了其地理覆蓋範圍和擴充性。
人們對遠距藥事照護的認知不斷提高
人們對遠距藥事照護的認知不斷提高,這帶來了巨大的市場機會。隨著遠端醫療,遠距藥事照護的益處也日益受到認可,尤其是在服務不足的地區,這些益處包括改善藥物服務的可及性、加強藥物管理以及擴大醫療服務遠距藥事照護透過加速遠距藥事照護解決方案的採用和部署,並鼓勵患者和舉措提供者使用這些遠距服務,從而促進遠距藥學計畫的更廣泛實施。
隱私和資料安全風險
遠端處理高度敏感的患者資訊會增加遭受網路威脅、資料外洩和未授權存取的風險。保護病患隱私並嚴格遵守隱私法規是重中之重。不當處理或未經授權披露健康數據會損害患者信任,並可能導致法律訴訟,進一步阻礙市場擴張。
新冠疫情顯著加速了遠距藥事照護解決方案的普及。這場危機凸顯了遠端醫療的必要性,以及人們對遠端醫療和遠距藥事照護服務的日益依賴。封鎖、保持社交距離以及醫療機構的限制,促使患者和醫療服務提供者開始接受透過遠距藥事照護平台進行遠距諮詢、處方箋更新和藥物管理。這種需求的激增展現了遠距藥事照護在確保醫療服務連續性方面的巨大潛力,並推動了遠距藥學服務的長期轉型。
在預測期內,患者諮詢領域預計將佔據最大的市場佔有率。
患者諮詢領域預計將成為遠距藥事照護市場的主要驅動力,因為它在藥物管理和以患者為中心的護理中發揮著至關重要的作用。遠距藥事照護能夠提供個人化諮詢,透過全面的用藥指導、劑量說明和副作用管理來支持患者。隨著醫療保健越來越重視患者參與和用藥依從性,遠距藥事照護提供遠距諮詢服務的能力變得至關重要,尤其是在慢性病和複雜治療方法。這種對個人化諮詢的需求正在推動患者諮詢行業的發展,凸顯了其在透過遠距藥事照護服務確保有效藥物護理方面的重要性。
在預測期內,醫院產業預計將呈現最高的複合年成長率。
隨著醫療保健格局的轉變,醫院領域預計將在遠距藥事照護市場迎來顯著成長。醫院正擴大採用遠距藥事照護來最佳化患者照護、簡化藥物管理並擴展遠距服務。將遠距藥事照護解決方案整合到醫院系統中,有助於提高患者的用藥依從性,並促進線上諮詢,尤其對出院患者和慢性病患者而言更是如此。此外,遠距藥事照護透過擴大醫療服務的覆蓋範圍、降低再入院率和確保持續的藥物支持,正在推動醫院領域的顯著成長。
北美地區憑藉其先進的醫療基礎設施、技術主導的創新以及成熟的遠端醫療環境,預計將在遠距藥事照護市場中佔據最大的市場佔有率。該地區擁有健全的法規結構,為遠距遠距藥事照護的普及應用提供了支援。此外,不斷上漲的醫療成本、人口老化以及對改善醫療服務可近性的日益重視,都在推動遠距藥物服務的需求。憑藉成熟的遠端保健實踐和廣泛的數位化連接,北美地區有望引領遠距藥事照護產業,並利用其技術優勢和醫療進步來滿足不斷變化的患者需求。
在亞太地區,由於醫療基礎設施的不斷完善、數位技術的普及以及對便捷醫療服務需求的日益成長,遠距藥事照護市場預計將迎來顯著成長。遠距藥事照護能夠克服地理限制,尤其是在偏遠地區,為人們提供便利的藥學專業知識。此外,該地區精通技術的人口以及對高效醫療服務體係日益成長的需求,進一步推動了遠距藥事照護解決方案的普及,使亞太地區成為遠距藥學服務領域極具發展潛力的地區。
According to Stratistics MRC, the Global Telepharmacy Market is accounted for $15.3 billion in 2026 and is expected to reach $59.0 billion by 2034 growing at a CAGR of 18.4% during the forecast period. Telepharmacy encompasses remote pharmaceutical services delivered via telecommunications and digital platforms. It enables pharmacists to provide medication consultations, therapy management and dispensing remotely. Telepharmacy enhances accessibility to pharmacy services, especially in underserved regions, facilitates medication adherence, and offers virtual consultations, aiding in patient care and medication support through remote interactions and technological solutions.
According to the National Institute of Health (NIH) survey on patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy during the COVID-19 pandemic, about 77% of respondents preferred appointments via telepharmacy.
Growing demand for remote healthcare solutions
The increasing demand for remote healthcare solutions drives the telepharmacy market. Factors such as geographic barriers, limited access to pharmacies and the need for convenient healthcare options, especially in rural or underserved areas, fuel this demand. Telepharmacy addresses these challenges by offering remote pharmaceutical services, including medication consultations, therapy management, and prescription refills. The growing preference for virtual interactions, coupled with the desire for accessible and timely healthcare, positions telepharmacy as a pivotal solution, propelling its adoption and market growth.
Challenges in obtaining licenses across different jurisdictions
Different regulations and licensing requirements in different regions or states demand complex compliance procedures. Telepharmacy services operating across multiple jurisdictions must navigate varied legal frameworks, which often involve rigorous and time-consuming processes for licensure. The need for adherence to distinct regulations complicates operations, increases administrative burdens, and hampers swift market expansion. This challenge of navigating diverse licensing requirements across jurisdictions impedes the seamless delivery of telepharmacy services, limiting geographic reach and scalability.
Growing awareness regarding the telepharmacy
The increasing awareness surrounding telepharmacy presents a significant opportunity in the market. As remote healthcare solutions grow among patients and healthcare providers, there's heightened recognition of the benefits telepharmacy offers, including improved accessibility to pharmaceutical services, enhanced medication management and expanded healthcare reach, especially in underserved areas. This awareness fosters greater acceptance and adoption of telepharmacy solutions, encouraging both patients and healthcare organizations to embrace these remote services, thereby driving the market's growth and facilitating a more widespread implementation of telepharmacy initiatives.
Privacy and data security risks
Handling sensitive patient information remotely increases vulnerability to cyber threats, data breaches and unauthorized access. Protecting patient confidentiality and complying with stringent privacy regulations have become paramount. Mishandling or unauthorized disclosure of health data erodes patient trust and could lead to legal repercussions, which further hinders market expansion.
The COVID-19 pandemic significantly accelerated the adoption of telepharmacy solutions. The crisis highlighted the need for remote healthcare access, prompting increased reliance on telemedicine and telepharmacy services. Lockdowns, social distancing measures and healthcare facility limitations pushed patients and providers to embrace remote consultations, prescription refills and medication management through telepharmacy platforms. This surge in demand showcased telepharmacy's potential in ensuring continuity of care, shaping a long-term shift towards remote pharmaceutical services.
The patient counselling segment is expected to be the largest during the forecast period
The patient counselling segment is expected to dominate the telepharmacy market due to its pivotal role in medication management and patient-centric care. Telepharmacy facilitates personalized counseling, empowering patients with comprehensive medication guidance, dosage instructions, and adverse effects management. As healthcare increasingly focuses on patient engagement and adherence, telepharmacy's ability to offer remote counseling services, especially for chronic conditions or complex therapies, becomes crucial. This demand for tailored counseling propels the patient counselling segment, emphasizing its significance in ensuring effective pharmaceutical care through telepharmacy services.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to experience substantial growth in the telepharmacy market due to evolving healthcare dynamics. Hospitals increasingly adopt telepharmacy to optimize patient care, streamline medication management, and extend services remotely. The integration of telepharmacy solutions within hospital systems enhances medication adherence and facilitates virtual consultations, especially for discharged patients or those with chronic conditions. Additionally, telepharmacy augments healthcare access, reducing readmission rates and ensuring continuous medication support, positioning the hospitals segment for significant expansion.
North America is expected to register the largest market share in the telepharmacy market, owing to its advanced healthcare infrastructure, tech-driven innovation, and mature telehealth landscape. The region boasts robust regulatory frameworks supporting telepharmacy adoption. Furthermore, increased healthcare spending, a growing aging population, and the emphasis on improving healthcare access drive the demand for remote pharmaceutical services. With established telehealth practices and widespread digital connectivity, North America is primed to lead in telepharmacy, leveraging its technological prowess and healthcare advancements to cater to evolving patient needs.
Asia Pacific is set to witness substantial growth in the telepharmacy market due to the region's expanding healthcare infrastructure, increasing adoption of digital technology and rising demand for accessible healthcare services. Telepharmacy addresses geographical barriers, especially in remote areas, by offering convenient access to pharmaceutical expertise. Moreover, the region's tech-savvy population and the escalating need for efficient healthcare delivery systems further propel the adoption of telepharmacy solutions, positioning Asia Pacific for lucrative growth in remote pharmaceutical services.
Key players in the market
Some of the key players in telepharmacy market include Capsule Technologies, CPS Solutions, LLC, Digital Pharmacist Inc., McKesson Ventures, Medication Review, Inc., Medtel Communications, Omnicell, Inc., PharmaPoint, PioneerRx, Pipeline Healthcare, TelePharm (Cardinal Health), Transaction Data Systems, Inc. and ZipDrug.
In May 2023, OneroRx is pleased to announce that Community Pharmacy of Dunlap is open to serve residents of Dunlap, Iowa, and its surrounding communities. Community Pharmacy has worked closely with Dunlap Community Development Corporation (DCDC) to bring pharmacy services back to the area.
In July 2022, RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup's round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal Health(TM), a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions in health care. RxLive has raised a total of $8 million to date.